Cargando…
CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer
Introduction. Sensitive and specific imaging of pancreas cancer are necessary for accurate diagnosis, staging, and treatment. The vast majority of pancreas cancers express the carbohydrate tumor antigen CA19-9. The goal of this study was to determine the potential to target CA19-9 with a radiolabele...
Autores principales: | Girgis, Mark D., Olafsen, Tove, Kenanova, Vania, McCabe, Katelyn E., Wu, Anna M., Tomlinson, James S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168788/ https://www.ncbi.nlm.nih.gov/pubmed/21912743 http://dx.doi.org/10.1155/2011/834515 |
Ejemplares similares
-
Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
por: Girgis, Mark D, et al.
Publicado: (2011) -
Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology †
por: Rangger, Christine, et al.
Publicado: (2020) -
Evaluation of Two Internalizing Carcinoembryonic Antigen Reporter Genes for Molecular Imaging
por: Barat, Bhaswati, et al.
Publicado: (2010) -
Positron Emission Tomography Imaging of Endometrial Cancer Using Engineered Anti-EMP2 Antibody Fragments
por: Fu, Maoyong, et al.
Publicado: (2012) -
Automated light-induced synthesis of (89)Zr-radiolabeled antibodies for immuno-positron emission tomography
por: Klingler, Simon, et al.
Publicado: (2022)